Rockville, MD, Nov. 01, 2016 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases, today announced that the Company's management will participate in two upcoming investor conferences. These two conferences include:
- Credit Suisse 25 th Annual Healthcare Conference in Scottsdale, Arizona. MacroGenics' presentation is scheduled to take place on Tuesday, November 8, 2016 at 3:00 pm MT (5:00 pm ET).
- Stifel 2016 Healthcare Conference in New York. MacroGenics' presentation is scheduled to take place on Wednesday, November 16, 2016 at 11:00 am ET.
Contacts:Jim Karrels, Senior Vice President, CFOMacroGenics, Inc.1-301-251-5172, email@example.comKaren Sharma, Senior Vice PresidentMacDougall Biomedical Communications1-781-235-3060, firstname.lastname@example.org